Dr Reddys Laboratories (RDY) Long-Term Investments (2009 - 2026)

Dr Reddys Laboratories' Long-Term Investments history runs 10 years deep, the most recent figure standing at $114.0 million for Q1 2026.

• In Q1 2026, Long-Term Investments rose 103.57% year-over-year to $114.0 million; the TTM figure through Mar 2026 stood at $114.0 million (up 103.57% YoY), while the FY2026 annual figure was $114.0 million, up 103.57% from the prior year.
• Long-Term Investments for Q1 2026 stood at $114.0 million, up from $56.0 million in the prior quarter.
• The five-year high for Long-Term Investments was $114.0 million in Q1 2026, with the low at $8.0 million in Q1 2023.
• The 5-year median for Long-Term Investments is $56.0 million (2025), against an average of $49.6 million.
• The sharpest annual moves came in 2023 and 2025: Long-Term Investments slumped 85.96% in 2023, then surged 330.77% in 2025.
• Dr Reddys Laboratories' Long-Term Investments stood at $57.0 million in 2022, then plunged by 85.96% to $8.0 million in 2023, then jumped by 62.5% to $13.0 million in 2024, then soared by 330.77% to $56.0 million in 2025, then surged by 103.57% to $114.0 million in 2026.
• Business Quant data shows RDY's Long-Term Investments at $114.0 million in Q1 2026, $56.0 million in Q1 2025, and $13.0 million in Q1 2024.